21/06/2024 Healthcare
Teicoplanin Injection IP, sold under the brand Satcopin-400 Injection, is a glycopeptide antibiotic used for treating severe bacterial infections, particularly those resistant to other antibiotics. Administered intravenously, it targets Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Satcopin-400 Injection offers prolonged antibacterial activity with less frequent dosing due to its long half-life. It is essential in hospital settings for treating complicated infections, ensuring effective therapy against resistant pathogens.Available in PCD Franchise for injectable range and third party manufacturing.
Teicoplanin Injection IP, sold under the brand Satcopin-400 Injection, is a glycopeptide antibiotic used for treating severe bacterial infections, par...
Vancomycin Hydrochloride for Injection IP, branded as Satdox-500 Injection, is a potent antibiotic used to treat severe infections caused by Gram-posi...
Vancomycin for Injection IP, marketed as Satdox Injection, is a potent antibiotic effective against Gram-positive bacteria, including methicillin-resi...
Triamcinolone Acetonide Injection IP, known as Tioxlin-40 Injection, is a corticosteroid used for its anti-inflammatory and immunosuppressive properti...
More Details